Abstract
Purpose Polycystic ovary syndrome (PCOS) is a complex disorder with heterogenous phenotypes and unclear etiology. A recent phenotypic clustering study identified metabolic and reproductive subtypes of PCOS. We attempted to deconstruct the PCOS heterogeneity from a genetic perspective.
Methods We applied k-means clustering to categorize the genome-wide significant PCOS variants into clusters based on their associations with selected quantitative traits that likely reflect PCOS etiological pathways. We evaluated the association of each cluster with PCOS related traits and disease outcomes. We then applied Mendelian randomization to estimate the causal effect of the traits on PCOS and PCOS on disease outcomes.
Results Clustering analysis suggested three categories of variants: adiposity, insulin resistant, and reproductive. Significant associations were observed for variants in the adiposity cluster with body mass index (BMI), waist circumference and breast cancer, and variants in insulin resistant cluster with fasting insulin and glucose values, and homeostatic model assessment of insulin resistance (HOMA-IR). Sex hormone binding globulin (SHBG) has strong association with all three clusters. Mendelian randomization supported the causal role of BMI and SHBG on PCOS. No causal associations were observed for PCOS on disease outcomes.
Main Conclusions Our study provides genetic evidence for the heterogeneity in PCOS etiologies, corresponding to the reported phenotypic subtypes. Such studies will improve the current PCOS diagnosis criteria that do not distinguish the heterogeneity. Classification of women with PCOS to inform appropriate treatment will be more accurate in the future with improvements in clustering analysis for PCOS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is exempted from an IRB review because only summary data were used.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in this study are from public dataset and the references were provided in the method and supplementary notes.
